Skip to content
ApprovedFDA approvedStrong evidence

Amisulpride

Prescription antipsychotic that, at lower doses, was also found in studies to work in milder, long-lasting depression.

AntidepressantDopaminergicAntidepressantMoodDopamineSerotonin
Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Pharmacology

ClassAntidepressant · Mood
Primary targetPresynaptic dopamine D2 autoreceptor antagonism
Targets3 receptor targets
Half-lifeAbout 12 hours; excreted largely unchanged via the kidneys
OnsetAntidepressant effect at low dose often within 1-2 weeks
EvidenceStrong evidence
Affected systemsDopamineSerotonin

Contents

DETAILED OVERVIEW

What is Amisulpride?

Amisulpride is a prescription medicine, an atypical antipsychotic, that is, a drug used for schizophrenia. As Solian and Deniban it is licensed in several EU countries, Hungary included; its oral form is not approved in the United States.

Its effect depends on the amount taken: at lower doses it blocks the nerve endings that hold back dopamine release, so dopamine rises and the effect is energizing and mood-lifting; at higher doses it blocks dopamine receptors, which gives the antipsychotic effect. In long-lasting, milder depression (dysthymia), studies found a response similar to or faster than usual antidepressants. It can raise the hormone prolactin, which may cause milk production and sexual problems. It can also lengthen the QT interval seen on an ECG, which carries a risk of heart-rhythm problems. It must not be used in kidney failure, Parkinson's disease or prolactin-dependent tumors, and its safety in pregnancy and breastfeeding has not been shown.

Mechanism

D2/D3 antagonist + 5-HT7 antagonist (dose-dependent)

Half-life

About 12 hours (renally cleared)

Legal status

Prescription (licensed in the EU)

Receptor profile

  • Dopamine D2 receptor (presynaptic autoreceptor)Strong
  • Dopamine D3 receptorStrong
  • 5-HT7 serotonin receptor (antagonist)Moderate

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • Hyperprolactinemia: raised prolactin causing galactorrhea, amenorrhea, sexual dysfunction and reduced libido
  • Extrapyramidal symptoms at higher (antipsychotic) doses: tremor, rigidity, akathisia
  • Insomnia, anxiety or restlessness, especially with low-dose activating use
  • Weight gain and metabolic changes with prolonged use
  • QT-interval prolongation on ECG, with dose-dependent cardiac rhythm risk
  • Gastrointestinal complaints: nausea, constipation, dry mouth

Contraindications · 6

  • Contraindicated in prolactin-dependent tumors (e.g. breast cancer, pituitary prolactinoma)
  • Pheochromocytoma: disturbing catecholaminergic balance can be dangerous
  • Renal impairment: the drug is cleared mainly by the kidneys and can accumulate
  • Congenital long-QT syndrome or combination with other QT-prolonging drugs
  • Pregnancy and breastfeeding: safety not established, only after medical assessment
  • Parkinson's disease: dopamine antagonism can worsen motor symptoms

Related Nootropics

Same therapeutic category

Studies

Related research and clinical findings

FAQ

FAQ

Amisulpride is a prescription medication used at higher doses to treat certain symptoms of schizophrenia, such as withdrawal and low motivation, while at low doses it's used as a mood-lifting, antidepressant-type treatment for persistent, milder depression. In studies its effect matched or came on faster than standard antidepressants, and its side-effect profile was more favorable at low doses.

Telegram

Have a question about Amisulpride?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeAntidepressant
FormulaC17H27N3O4S
UpdatedOctober 13, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 13, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.